Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives

Nippon rinsho. Japanese journal of clinical medicine

Volumn 59, Issue 6, 2001, Pages 1132-1138

  Saji, T ^a   Nakayama, T ^a   Ishikita, T ^a   Matsuura, H ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ILOPROST; PROSTACYCLIN;

HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PULMONARY HYPERTENSION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS;

EID: 0035374602     PISSN: 00471852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)